Publications by authors named "Maria Sitarou"

Claim this Profile
E
Evaluation of Five Plasma miRNAs as Biomarkers for Minimally Invasive Staging of Liver Fibrosis in β-Thalassaemia Patients.
Sevgi Özkaramehmet, Savanna Andreou, Kristia Yiangou, Soteroula Christou, Michalis Hadjigavriel, Maria Sitarou

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Context base editing for splice correction of IVSI-110 β-thalassemia.
Basma Naiisseh, Panayiota L Papasavva, Nikoletta Y Papaioannou, Marios Tomazou, Lola Koniali, Maria Sitarou

Mol Ther Nucleic Acids· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Mono- and Bi-Functional GLOBE-Based Vectors for Therapy of β-Thalassemia by Gene Addition and Mutation-Specific RNA Interference.
Lola Koniali, Christina Flouri, Markela I Kostopoulou, Nikoletta Y Papaioannou, Panayiota L Papasavva, Maria Sitarou

Cells· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on mRNA synthesis.
Nikoletta Y Papaioannou, Petros Patsali, Basma Naiisseh, Panayiota L Papasavva, Lola Koniali, Maria Sitarou

Front Genome Ed· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of HBB genotype on survival in a cohort of transfusion-dependent thalassemia patients in Cyprus.
Petros Kountouris, Kyriaki Michailidou, Soteroula Christou, Michael Hadjigavriel, Maria Sitarou

Haematologica· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-specific transcriptional profiles identified in β-thalassemia patients.
Aikaterini Nanou, Chrisavgi Toumpeki, Pavlos Fanis, Nicoletta Bianchi, Lucia Carmela Cosenza, Maria Sitarou

Haematologica· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct miRNA Signatures and Networks Discern Fetal from Adult Erythroid Differentiation and Primary from Immortalized Erythroid Cells.
Panayiota L Papasavva, Nikoletta Y Papaioannou, Petros Patsali, Ryo Kurita, Yukio Nakamura, Maria Sitarou

Int J Mol Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative and Absolute Quantification of Aberrant and Normal Splice Variants in β-Thalassemia.
Petros Patsali, Panayiota Papasavva, Soteroulla Christou, Maria Sitarou, Michael N Antoniou

Int J Mol Sci· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic Studies for the Investigation of γ-Globin Induction by Decitabine in Human Primary Erythroid Progenitor Cultures.
Andria Theodorou, Marios Phylactides, Eleni Katsantoni, Kostas Vougas, Spyros D Garbis, Maria Sitarou

J Clin Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas-and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells.
Petros Patsali, Giandomenico Turchiano, Panayiota Papasavva, Marianna Romito, Constantinos C Loucari, Maria Sitarou

Haematologica· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements.
Petros Patsali, Claudio Mussolino, Petros Ladas, Argyro Floga, Annita Kolnagou, Maria Sitarou

J Clin Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel mutation in the erythroid transcription factor KLF1 is likely responsible for ameliorating β-thalassemia major.
Pavlos Fanis, Ioanna Kousiappa, Marios Phylactides, Andreani Kyrri, Michael Hadjigavriel, Maria Sitarou

Hum Mutat· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-hairpin RNA against aberrant mRNA restores β-globin levels in a novel cell model and acts as mono- and combination therapy for β-thalassemia in primary hematopoietic stem cells.
Petros Patsali, Panayiota Papasavva, Coralea Stephanou, Soteroulla Christou, Maria Sitarou

Haematologica· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies.
Constantinos C Loucari, Petros Patsali, Thamar B van Dijk, Coralea Stephanou, Panayiota Papasavva, Maria Sitarou

Hum Gene Ther Methods· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hb A Episkopi - a novel δ-globin chain variant [HBD:c.428C>T] in a family of mixed Cypriot-Lebanese descent.
Carsten W Lederer, Eleni Pavlou, George A Tanteles, Paola Evangelidou, Carolina Sismani, Maria Sitarou

Hematology· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular spectrum and distribution of haemoglobinopathies in Cyprus: a 20-year retrospective study.
Petros Kountouris, Ioanna Kousiappa, Thessalia Papasavva, George Christopoulos, Eleni Pavlou, Maria Sitarou

Sci Rep· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hb Famagusta--analysis of a novel δ-globin chain variant [HBD:c.60C>A] in four families with diverse globin genotypes.
Carsten W Lederer, Eleni Pavlou, Christiana Makariou, Georgia Hadjilambi, Nicoletta Andreou, Maria Sitarou

Ann Hematol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone.
Paul T Telfer, Fiona Warburton, Soteroula Christou, Michael Hadjigavriel, Maria Sitarou

Haematologica· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004.
Paul Telfer, Pietro G Coen, Soteroula Christou, Michael Hadjigavriel, Anita Kolnakou, Maria Sitarou

Haematologica· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on fertility in thalassaemia major.
Nicos Skordis, Loizos Petrikkos, Meropi Toumba, Michael Hadjigavriel, Maria Sitarou

Pediatr Endocrinol Rev· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis